Industry veteran named as Biofilm CEO

The former chief executive of Scottish life sciences firms Touch Bionics and Mpathy Medical has been appointed toheadupglasgow-basedbiofilm.

Ian Stevens takes over as chief executive at the firm, which develops and manufactures thin dissolving films that release active ingredients, from founder Trevor Morgan who is retiring.

Biofilm, which was established in a management buyout from Devro, has backers including Tate & Lyle Ventures and Scottish Enterprise. Its products are used in drugs, dietary supplements, cosmetics, oral hygiene products and medical devices.

Chairman Peter Shotter said Stevens was joining the business at an exciting stage in its development.

“We look forward to him helping the company continue the growth achieved to date by Trevor Morgan and his management team,” he added.

Stevens left Livingstonbased artificial limb firm Touch Bionics after its sale to Icelandic orthotic and prosthetic manufacturer Össur in a deal worth £27.5 million in 2016.

Touch Bionics, whose shareholders included Archangel Investors and the Scottish Investment Bank, had been spun out of the NHS in Scotland.

As well as running Mpathy, which was sold to Danish surgical medical device manufacturer Coloplast in 2010, Stevens also spent almost a decade at Dunfermline based retinal imaging firm Optos where he was chief financial officer and later head of its North American operation. 0 Ian Stevens is taking over as CEO at the Glasgow firm